Thiopurines in the Management of Crohn’s Disease: Safety and Efficacy Profile in Patients with Normal TPMT Activity—A Retrospective Study
Background and Aims. Thiopurines are used in the treatment of Crohn’s disease (CD) and thiopurine S-methyltransferase (TPMT) activity can guide thiopurine dosing to avoid adverse events. This retrospective study evaluated the safety and efficacy of starting thiopurines at low dose versus full dose i...
Saved in:
Main Authors: | Amine Benmassaoud, Xuanqian Xie, Motaz AlYafi, Yves Theoret, Alain Bitton, Waqqas Afif, Talat Bessissow |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Canadian Journal of Gastroenterology and Hepatology |
Online Access: | http://dx.doi.org/10.1155/2016/1034834 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical Outcomes of COVID-19 and Impact on Disease Course in Patients with Inflammatory Bowel Disease
by: Panu Wetwittayakhlang, et al.
Published: (2021-01-01) -
Personalization of thiopurine therapy: Current recommendations and future perspectives
by: Urbančič Dunja, et al.
Published: (2024-09-01) -
Thiopurines Induce Oxidative Stress in T-Lymphocytes: A Proteomic Approach
by: Misbah Misdaq, et al.
Published: (2015-01-01) -
The Utility of Thiopurine Methyltransferase Enzyme Testing in Inflammatory Bowel Disease
by: Laura Chisick, et al.
Published: (2013-01-01) -
Canadian Association of Gastroenterology Clinical Practice Guidelines: The Use of Tumour Necrosis Factor-Alpha Antagonist Therapy in Crohn’s Disease
by: Daniel C Sadowski, et al.
Published: (2009-01-01)